These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 10574918)
1. Enhancement of heparin cofactor II anticoagulant activity. Bauman SJ; Church FC J Biol Chem; 1999 Dec; 274(49):34556-65. PubMed ID: 10574918 [TBL] [Abstract][Full Text] [Related]
2. Aspartic acid residues 72 and 75 and tyrosine-sulfate 73 of heparin cofactor II promote intramolecular interactions during glycosaminoglycan binding and thrombin inhibition. Mitchell JW; Church FC J Biol Chem; 2002 May; 277(22):19823-30. PubMed ID: 11856753 [TBL] [Abstract][Full Text] [Related]
3. Arginine 200 of heparin cofactor II promotes intramolecular interactions of the acidic domain. Implication for thrombin inhibition. Ciaccia AV; Monroe DM; Church FC J Biol Chem; 1997 May; 272(22):14074-9. PubMed ID: 9162031 [TBL] [Abstract][Full Text] [Related]
4. The N-terminal acidic domain of heparin cofactor II mediates the inhibition of alpha-thrombin in the presence of glycosaminoglycans. Van Deerlin VM; Tollefsen DM J Biol Chem; 1991 Oct; 266(30):20223-31. PubMed ID: 1939083 [TBL] [Abstract][Full Text] [Related]
5. Substitution of arginine for Leu444 in the reactive site of heparin cofactor II enhances the rate of thrombin inhibition. Derechin VM; Blinder MA; Tollefsen DM J Biol Chem; 1990 Apr; 265(10):5623-8. PubMed ID: 2138609 [TBL] [Abstract][Full Text] [Related]
6. Site-directed mutagenesis of arginine 103 and lysine 185 in the proposed glycosaminoglycan-binding site of heparin cofactor II. Blinder MA; Tollefsen DM J Biol Chem; 1990 Jan; 265(1):286-91. PubMed ID: 2104620 [TBL] [Abstract][Full Text] [Related]
7. Characterization of recombinant heparin cofactor II expressed in insect cells. Ciaccia AV; Cunningham EL; Church FC Protein Expr Purif; 1995 Dec; 6(6):806-12. PubMed ID: 8746633 [TBL] [Abstract][Full Text] [Related]
8. Heparin facilitates dissociation of complexes between thrombin and a reactive site mutant (L444R) of heparin cofactor II. Han JH; Van Deerlin VM; Tollefsen DM J Biol Chem; 1997 Mar; 272(13):8243-9. PubMed ID: 9079643 [TBL] [Abstract][Full Text] [Related]
9. Contribution of basic residues of the A helix of heparin cofactor II to heparin- or dermatan sulfate-mediated thrombin inhibition. Hayakawa Y; Hirashima Y; Kurimoto M; Hayashi N; Hamada H; Kuwayama N; Endo S FEBS Lett; 2002 Jul; 522(1-3):147-50. PubMed ID: 12095635 [TBL] [Abstract][Full Text] [Related]
10. Heparin promotes proteolytic inactivation by thrombin of a reactive site mutant (L444R) of recombinant heparin cofactor II. Ciaccia AV; Willemze AJ; Church FC J Biol Chem; 1997 Jan; 272(2):888-93. PubMed ID: 8995378 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of thrombin by sulfated polysaccharides isolated from green algae. Hayakawa Y; Hayashi T; Lee J; Srisomporn P; Maeda M; Ozawa T; Sakuragawa N Biochim Biophys Acta; 2000 Nov; 1543(1):86-94. PubMed ID: 11087944 [TBL] [Abstract][Full Text] [Related]
12. Heparin cofactor II is regulated allosterically and not primarily by template effects. Studies with mutant thrombins and glycosaminoglycans. Sheehan JP; Tollefsen DM; Sadler JE J Biol Chem; 1994 Dec; 269(52):32747-51. PubMed ID: 7806495 [TBL] [Abstract][Full Text] [Related]
13. Role of thrombin anion-binding exosite-I in the formation of thrombin-serpin complexes. Myles T; Church FC; Whinna HC; Monard D; Stone SR J Biol Chem; 1998 Nov; 273(47):31203-8. PubMed ID: 9813026 [TBL] [Abstract][Full Text] [Related]
14. Activation of heparin cofactor II by calcium spirulan. Hayakawa Y; Hayashi T; Lee JB; Ozawa T; Sakuragawa N J Biol Chem; 2000 Apr; 275(15):11379-82. PubMed ID: 10753952 [TBL] [Abstract][Full Text] [Related]
15. Comparison of heparin- and dermatan sulfate-mediated catalysis of thrombin inactivation by heparin cofactor II. Liaw PC; Austin RC; Fredenburgh JC; Stafford AR; Weitz JI J Biol Chem; 1999 Sep; 274(39):27597-604. PubMed ID: 10488098 [TBL] [Abstract][Full Text] [Related]
16. Effect of oligodeoxynucleotide thrombin aptamer on thrombin inhibition by heparin cofactor II and antithrombin. Holland CA; Henry AT; Whinna HC; Church FC FEBS Lett; 2000 Nov; 484(2):87-91. PubMed ID: 11068038 [TBL] [Abstract][Full Text] [Related]
17. Mutagenesis of thrombin selectively modulates inhibition by serpins heparin cofactor II and antithrombin III. Interaction with the anion-binding exosite determines heparin cofactor II specificity. Sheehan JP; Wu Q; Tollefsen DM; Sadler JE J Biol Chem; 1993 Feb; 268(5):3639-45. PubMed ID: 8429040 [TBL] [Abstract][Full Text] [Related]
18. Depolymerized holothurian glycosaminoglycan with novel anticoagulant actions: antithrombin III- and heparin cofactor II-independent inhibition of factor X activation by factor IXa-factor VIIIa complex and heparin cofactor II-dependent inhibition of thrombin. Nagase H; Enjyoji K; Minamiguchi K; Kitazato KT; Kitazato K; Saito H; Kato H Blood; 1995 Mar; 85(6):1527-34. PubMed ID: 7888673 [TBL] [Abstract][Full Text] [Related]
19. Role of lysine 173 in heparin binding to heparin cofactor II. Whinna HC; Blinder MA; Szewczyk M; Tollefsen DM; Church FC J Biol Chem; 1991 May; 266(13):8129-35. PubMed ID: 1902471 [TBL] [Abstract][Full Text] [Related]
20. Molecular mapping of the thrombin-heparin cofactor II complex. Fortenberry YM; Whinna HC; Gentry HR; Myles T; Leung LL; Church FC J Biol Chem; 2004 Oct; 279(41):43237-44. PubMed ID: 15292227 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]